Clinical shares soar on market debut
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SHARES in the stock market newcomer Clinical Computing, a supplier of specialist medical software, rose 40 per cent to 173p on the first day of dealing, writes Diane Coyle.
The company made pre-tax profits of pounds 1.2m on turnover of pounds 2.6m in the year to 31 December 1993. The pounds 3.1m raised by the placing of 25 per cent of its shares will be used for product development and to create a sales and distribution network.
One advance will be in Clinical's Proton software. Future versions will be 'open systems' products that can run on any computer without adaptation. Clinical already has a prototype that incorporates the popular Microsoft Windows displays.
Clinical's directors said they intended to enhance shareholder value through capital growth rather than high yield.
Lionel Arbis, analyst at stockbroker Greig Middleton, said: 'The share price puts the company on a demanding rating. But it has a good product and no significant competition.' Last year's 6.27p earnings per share implies a price earnings multiple of 27.5.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments